Groen HJ - Search Results

1

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Derks JL, van Suylen RJ, Thunnissen E, den Bakker MA, Groen HJ, Smit EF, Damhuis RA, van den Broek EC, Speel EM, Dingemans AC; PALGA group. Derks JL, et al. Among authors: groen hj. Eur Respir J. 2017 Jun 1;49(6):1601838. doi: 10.1183/13993003.01838-2016. Print 2017 Jun. Eur Respir J. 2017. PMID: 28572122 Free PMC article.

2

Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer.

Groen HJ, Smit EF, Haaxma-Reiche H, Postmus PE. Groen HJ, et al. Eur J Cancer. 1993;29A(12):1696-9. doi: 10.1016/0959-8049(93)90107-q. Eur J Cancer. 1993. PMID: 7691116

3

Surgical resection for small cell carcinoma of the lung: a retrospective study.

Smit EF, Groen HJ, Timens W, de Boer WJ, Postmus PE. Smit EF, et al. Among authors: groen hj. Thorax. 1994 Jan;49(1):20-2. doi: 10.1136/thx.49.1.20. Thorax. 1994. PMID: 8153935 Free PMC article.

4

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.

Bakker M, Groen HJ, Smit EF, Smeets J, Riggi M, Postmus PE. Bakker M, et al. Among authors: groen hj. Br J Cancer. 1995 Dec;72(6):1547-50. doi: 10.1038/bjc.1995.545. Br J Cancer. 1995. PMID: 8519675 Free PMC article. Clinical Trial.

5

Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatin.

Groen HJ, van der Mark TW, van der Leest AH, de Vries EG, Mulder NH. Groen HJ, et al. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2044-8. doi: 10.1164/ajrccm.152.6.8520774. Am J Respir Crit Care Med. 1995. PMID: 8520774

6

Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma.

Kosterink JG, de Jonge MW, Smit EF, Piers DA, Kengen RA, Postmus PE, Shochat D, Groen HJ, The HT, de Leij L. Kosterink JG, et al. Among authors: groen hj. J Nucl Med. 1995 Dec;36(12):2356-62. J Nucl Med. 1995. PMID: 8523132 Free article.

7

New prognostic factors in resectable non-small cell lung cancer.

Smit EF, Groen HJ, Splinter TA, Ebels T, Postmus PE. Smit EF, et al. Among authors: groen hj. Thorax. 1996 Jun;51(6):638-46. doi: 10.1136/thx.51.6.638. Thorax. 1996. PMID: 8693450 Free PMC article. Review. No abstract available.

8

Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.

Postmus PE, Scagliotti G, Groen HJ, Gozzelino F, Burghouts JT, Curran D, Sahmoud T, Kirkpatrick A, Giaccone G, Splinter TA. Postmus PE, et al. Among authors: groen hj. Eur J Cancer. 1996 Aug;32A(9):1498-503. doi: 10.1016/0959-8049(96)00145-1. Eur J Cancer. 1996. PMID: 8911108 Clinical Trial.

9

Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell lines.

Bakker M, Renes J, Groenhuijzen A, Visser P, Timmer-Bosscha H, Müller M, Groen HJ, Smit EF, de Vries EG. Bakker M, et al. Among authors: groen hj. Int J Cancer. 1997 Nov 4;73(3):362-6. doi: 10.1002/(sici)1097-0215(19971104)73:3<362::aid-ijc10>3.0.co;2-f. Int J Cancer. 1997. PMID: 9359483

10

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.

Smit EF, Fokkema E, Biesma B, Groen HJ, Snoek W, Postmus PE. Smit EF, et al. Among authors: groen hj. Br J Cancer. 1998;77(2):347-51. doi: 10.1038/bjc.1998.54. Br J Cancer. 1998. PMID: 9461009 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters